Patients with head and neck cancer may have impairment of some driving skillsSeptember 18, 2007A preliminary study suggests that patients with cancer in the head and neck region may have inferior performance in some driving skills compared with individuals without the disease, according to a report in the September issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals. "Driving is a complex task that requires adequate cognitive, psychomotor and visuoperceptualmotor functions that work together. These functions can be compromised to a greater or lesser extent in patients with cancer in the head and neck region who have received cancer treatment," the authors write. Side effects from cancer treatment may reduce head and neck mobility and may cause cognitive impairment, pain and psychological distress predisposing patients to greater driving risks. Hon K. Yuen, Ph.D., O.T.R./L., of the Medical University of South Carolina, Charleston, and colleagues used a virtual reality driving simulator to evaluate the driving skills of 10 patients with head and neck cancer (average age 56) and 50 members of the community (average age 48). Researchers recorded average speed, average brake reaction time, steering variability (vehicle offset from the center of driving lane in inches), the total number of collisions and the score of the Simulator Driving Performance Scale, which assesses participants' driving behavior and skills including braking properly at intersections, driving within the speed limit, using mirrors properly and staying a safe distance from other vehicles.
The median (midpoint) time between surgery and participation in the study was 26.6 months and the average time between cancer therapy and study participation was 20 months. The average brake reaction time and steering variability in the patients with cancer group were significantly longer (3,134.92 milliseconds vs. 2,299.8 milliseconds) and larger (271.26 inches vs. 46.45 inches), respectively, than those in the control group. There was not a significant difference between the two groups in average speed (21.8 miles per hour vs. 25.18 miles per hour), total number of collisions (1.1 vs. 1.4) or Simulator Driving Performance Scale scores. "This pilot study provides preliminary evidence indicating inferior driving performance in a group of patients with cancer in the head and neck region when compared with a community control group," the authors conclude. Further study is needed to investigate specific causes that may contribute to poor driving performance and the consequences this may have on driving in the real world for patients with cancer. JAMA and Archives Journals | |||||||||||||||||||||
|
Related Neck Cancer Current Events and Neck Cancer News Articles New platinum-phosphate compounds kill ovarian cancer cells A new class of compounds called phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than conventional drugs, according to a new study published this week in the journal Proceedings of the National Academy of Sciences. Survival of head and neck cancer patients is greatly affected by coexisting ailments Current estimates for head and neck cancer survival are largely inaccurate because they widely disregard many of the most common diseases such patients have in addition to their primary cancer, says Jay Piccirillo, M.D., a head and neck specialist at Washington University School of Medicine in St. Louis, the Siteman Cancer Center and Barnes-Jewish Hospital. Oral rinses used for tracking HPV-positive head and neck cancers holds promise for cancer screening A study published in the journal Clinical Cancer Research, a journal of the American Association for Cancer Research, validates a non-invasive screening method with future potential for detection of human papillomavirus (HPV)-positive head and neck cancers. News from Cancer: Disparities in head and neck cancer patients A new analysis finds considerable disparities in survival related to race and socio-economic status among patients with head and neck cancer. Joining forces against cancer In cancer therapy, the best results are often achieved by combining treatments such as chemotherapy, radiotherapy and surgery. As head and neck cancer risks evolve, more treatment options emerge Advances in understanding head and neck cancer over the last decade have led to more treatment options and improved quality of life for patients, according to a review published this week in the New England Journal of Medicine. Acupuncture reduces pain and dysfunction in head and neck cancer patients after neck dissection New data from a randomized, controlled trial found that acupuncture provided significant reductions in pain, dysfunction, and dry mouth in head and neck cancer patients after neck dissection. Quality of life predicts cancer survival, U-M study finds Head and neck cancer patients who reported lower physical quality of life were more likely to die from their disease, according to a new study from the University of Michigan Comprehensive Cancer Center. Gene therapy increases survival for end-stage head and neck cancer A gene therapy invented at The University of Texas M. D. Anderson Cancer Center is the first to succeed in a U.S. phase III clinical trial for cancer, as announced today at the American Society of Gene Therapy annual meeting in Boston. JAMA publication features UNMC study on depression and head and neck cancer A University of Nebraska Medical Center-led pilot study that showed antidepressants can significantly reduce the risk of depression for head and neck cancer patients is the focus of an article published today in the Archives of Otolaryngolgy -- one of the publications produced by the Journal of American Medical Association (JAMA). More Neck Cancer Current Events and Neck Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||